Talis Biomedical Corporat... (TLIS)

AI Score

Unlock

1.06

-0.54 (-33.75%)

At close: Apr 04, 2025, 9:37 AM

Talis Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	59.87M	70.34M	76.73M	88M	98.2M	112.96M	130.19M	143.78M	165.37M	187.59M	232.54M	273.6M	313.46M	348.01M	138.48M	55.41M	21.6M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	766K	1.54M	1.54M	1.54M	1.54M	1.54M	n/a	1.78M	1.78M	1.77M	767K	767K	767K	767K	n/a	n/a	n/a
Other Long-Term Assets	n/a	-1	1.54M	n/a	n/a	n/a	1.78M	n/a	n/a	4.53M	5.51M	981K	981K	981K	n/a	91K	91K
Receivables	n/a	6K	50K	5K	532K	127K	308K	433K	636K	2.6M	183K	219K	117K	n/a	471K	334K	1.81M
Inventory	n/a	n/a	n/a	n/a	1.01M	1.01M	n/a	2.03M	2.22M	3.5M	n/a	938K	37.08M	n/a	46.66M	48.87M	n/a
Other Current Assets	3.73M	827K	901K	1.53M	2.22M	1.49M	2.78M	4.13M	5.74M	7.14M	n/a	2.8M	37.86M	38.1M	37.76M	1.39M	430K
Total Current Assets	63.6M	71.17M	77.68M	89.53M	101.97M	115.59M	133.28M	150.38M	173.97M	200.82M	236.12M	277.56M	353.87M	391.32M	188.72M	106M	24.11M
Property-Plant & Equipment	8.33M	9.78M	15.45M	16.15M	19.57M	15.92M	34.23M	41.94M	45.95M	23.46M	23.43M	23.79M	23.93M	10.11M	9.68M	9.16M	1.53M
Goodwill & Intangibles	n/a	n/a	-1.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	9.1M	11.32M	20.66M	17.7M	21.11M	17.46M	36.01M	43.72M	47.72M	29.77M	29.71M	25.54M	25.67M	11.86M	9.68M	9.25M	1.63M
Total Assets	72.7M	82.49M	98.34M	107.23M	123.08M	133.05M	169.29M	194.09M	221.69M	230.59M	265.83M	303.1M	379.54M	403.18M	198.41M	115.25M	25.73M
Account Payables	3.79M	3.62M	1.34M	2.7M	2.49M	3.87M	3.77M	4.11M	3.98M	5.26M	5.12M	5.39M	11.7M	10.83M	4.91M	3.96M	1.57M
Deferred Revenue	-3.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.67M	23.85M	59.34M	34.67M	9.71M	n/a	n/a
Short-Term Debt	2.92M	n/a	2.88M	n/a	2.74M	2.96M	n/a	3M	2.33M	1.63M	n/a	1.13M	882K	491K	n/a	n/a	n/a
Other Current Liabilities	-2.07M	1.96M	954K	2.25M	361K	-229K	4.21M	488K	3.72M	4.34M	7.45M	6.49M	5.12M	5.21M	4.07M	2.6M	2.25M
Total Current Liabilities	8.2M	9.47M	8.77M	8.45M	9.26M	11.18M	12.67M	11.38M	13.9M	15.28M	19.11M	31.34M	72.63M	46.85M	16.03M	13.72M	4.04M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	-1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	290.95M	167.48M	42.84M
Total Long-Term Liabilities	15.88M	16.34M	20.45M	17.22M	17.65M	11.75M	29.88M	30.33M	30.77M	12.53M	12.74M	12.96M	13.18M	n/a	290.95M	167.48M	42.84M
Total Liabilities	24.07M	25.81M	29.22M	25.67M	26.91M	22.93M	42.55M	41.71M	44.67M	27.8M	31.85M	44.3M	85.81M	46.85M	306.98M	181.19M	46.87M
Total Debt	18.8M	19.24M	19.67M	20.08M	20.38M	14.71M	33.58M	33.33M	33.1M	14.15M	13.98M	14.09M	14.06M	491K	693K	825K	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	3K	n/a	3K	3K	3K	3K	2K	2K	2K	n/a	n/a	n/a
Retained Earnings	-561.85M	-553M	-539.96M	-526.5M	-510.82M	-495.79M	-477.95M	-451.02M	-425M	-397.99M	-364.94M	-336.29M	-297.87M	-233.4M	-172.91M	-128.71M	-81.78M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3K	n/a	n/a	n/a	-2.8M	-2.23M
Shareholders Equity	48.63M	56.68M	69.12M	81.56M	96.17M	110.12M	126.74M	152.39M	177.02M	202.78M	233.98M	258.79M	293.73M	356.33M	-108.57M	-65.94M	-21.14M
Total Investments	766K	1.54M	1.54M	1.54M	1.54M	1.54M	n/a	1.78M	1.78M	1.77M	767K	767K	767K	767K	n/a	n/a	n/a